We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Cannabinoid hyperemesis syndrome in pregnancy: Challenges and opportunities.
- Authors
Kirby, Jordan; Naren, Thileepan
- Abstract
Antenatal cannabis consumption is common and associated with adverse perinatal outcomes, including low birthweight, pre‐term birth and increased rates of admission to neonatal intensive care. Cannabinoid hyperemesis syndrome (CHS) comprises severe, cyclical episodes of vomiting, intractable nausea and abdominal pain observed in chronic cannabis users. CHS, particularly during pregnancy, poses a diagnostic dilemma with a tendency to be ineffectively managed secondary to reduced clinician awareness and a scarcity of available therapies. This clinical perspective explores the current literature on CHS in pregnancy, available pharmacotherapeutics, and recognises the current barriers to improving clinical care.
- Subjects
AUSTRALIA; CANNABINOID hyperemesis syndrome; MATERNAL health services; HEALTH services accessibility; CANNABIS (Genus); PROFESSIONS; PREMATURE infants; NAUSEA; SUBSTANCE abuse; DIFFERENTIAL diagnosis; PREGNANCY outcomes; LOW birth weight; VOMITING; QUALITY assurance; PUERPERIUM; ABDOMINAL pain; ANTIEMETICS
- Publication
Australian & New Zealand Journal of Obstetrics & Gynaecology, 2023, Vol 63, Issue 6, p746
- ISSN
0004-8666
- Publication type
Article
- DOI
10.1111/ajo.13714